Your NPR news source

BONUS: How Effective Are Antibody Treatments For COVID-19?

SHARE BONUS: How Effective Are Antibody Treatments For COVID-19?
Consider This : BONUS: How Effective Are Antibody Treatments For COVID-19? Image

A scientist works at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory. (Photo by JUAN MABROMATA / AFP) (Photo by JUAN MABROMATA/AFP via Getty Images)


The Food and Drug Administration has issued emergency use authorizations for two monoclonal antibody treatments for COVID-19 – one produced by Eli Lilly and another by Regeneron. But emergency use authorization doesn't assure the drugs are effective.

In this episode of Short Wave, NPR's daily science podcast, science correspondent Richard Harris explains how the new treatments work — and whether they could really make a difference for patients with COVID-19.

Listen to more episodes of Short Wave on Apple Podcasts or Spotify.

More From This Show
The Girl Scouts have been part of American childhood for generations. And now that quintessential experience is helping young girls, who are new to the United States get a sense of belonging. It comes through a Girl Scout troop based in one of New York City’s largest migrant shelters. The shelter has around 3,500 migrants, and all of the Girl Scouts are children of families seeking asylum. For the last few weeks, NPR’s Jasmine Garsd has been spending time with them, and brings us their their story. For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at Email us at Learn more about sponsor message choices: NPR Privacy Policy